- Home
- FSTR vs ABEO Comparison
FSTR vs ABEO Comparison
Compare FSTR & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSTR
- ABEO
- Stock Information
- Founded
- FSTR 1902
- ABEO N/A
- Country
- FSTR United States
- ABEO United States
- Employees
- FSTR N/A
- ABEO N/A
- Industry
- FSTR Metal Fabrications
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- FSTR Industrials
- ABEO Health Care
- Exchange
- FSTR Nasdaq
- ABEO Nasdaq
- Market Cap
- FSTR 272.1M
- ABEO 253.0M
- IPO Year
- FSTR N/A
- ABEO 1980
- Fundamental
- Price
- FSTR $26.85
- ABEO $5.78
- Analyst Decision
- FSTR Hold
- ABEO Strong Buy
- Analyst Count
- FSTR 1
- ABEO 4
- Target Price
- FSTR $25.00
- ABEO $17.25
- AVG Volume (30 Days)
- FSTR 33.5K
- ABEO 271.9K
- Earning Date
- FSTR 03-07-2025
- ABEO 03-17-2025
- Dividend Yield
- FSTR N/A
- ABEO N/A
- EPS Growth
- FSTR N/A
- ABEO N/A
- EPS
- FSTR 3.85
- ABEO N/A
- Revenue
- FSTR $537,459,000.00
- ABEO N/A
- Revenue This Year
- FSTR $0.44
- ABEO N/A
- Revenue Next Year
- FSTR $7.16
- ABEO $15,721.96
- P/E Ratio
- FSTR $6.97
- ABEO N/A
- Revenue Growth
- FSTR N/A
- ABEO 147.52
- 52 Week Low
- FSTR $14.23
- ABEO $3.05
- 52 Week High
- FSTR $30.77
- ABEO $9.01
- Technical
- Relative Strength Index (RSI)
- FSTR 44.23
- ABEO 52.03
- Support Level
- FSTR $27.41
- ABEO $5.79
- Resistance Level
- FSTR $28.52
- ABEO $6.16
- Average True Range (ATR)
- FSTR 0.94
- ABEO 0.23
- MACD
- FSTR -0.12
- ABEO 0.02
- Stochastic Oscillator
- FSTR 7.41
- ABEO 50.00
About FSTR L.B. Foster Company
L.B. Foster Co is a us-based firm engaged in the manufacturing, fabrication, and distribution of products and services, especially for the rail, construction, energy, and utility industries. The company operates its business through three segments: Rail Technologies and Services; Precast Concrete Products and Steel Products and Measurement. Its principal business activity involves providing new and used rail, trackwork, and accessories, producing concrete railroad ties, insulated rail joints, power rail, track fasteners, cover boards, and sales of sells and rents steel sheet piling, H-bearing pile, and other piling products for foundation and earth retention requirements. It generates the majority of its revenues from the Rail Technologies and Services segment.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.